Regencell Bioscience Holdings Limited Class Action Lawsuit
Company: Regencell Bioscience Holdings Limited
Ticker: (NASDAQ) RGC
Class Action Period: October 28, 2024 - October 31, 2025
See If You Qualify For Monetary Reward
Join the Regencell Bioscience Holdings Limited Class Action Lawsuit
CLASS ACTION PERIOD
October 28, 2024 - October 31, 2025
Allegations
The complaint filed against Regencell Bioscience Holdings Limited alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (i) Regencell was vulnerable and/or subject to market manipulation; (ii) the resulting volatility in the market for the Company’s ordinary shares exposed Regencell’s investors to significant financial risk; (iii) all the foregoing subjected Regencell to a heightened risk of regulatory and/or governmental scrutiny and enforcement action, as well as significant legal, monetary, and reputational harm; and (iv) as a result, defendants’ public statements were materially false and misleading at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on Regencell Bioscience Holdings Limited shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in Regencell Bioscience Holdings Limited during the relevant time frame, you have until June 23, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against Regencell Bioscience Holdings Limited (NASDAQ: RGC)?
Investors who purchased shares of Regencell Bioscience Holdings Limited (NASDAQ: RGC) during the class period (October 28, 2024 - October 31, 2025) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is June 23, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the Regencell Bioscience Holdings Limited lawsuit?
Anyone who bought shares of Regencell Bioscience Holdings Limited (NASDAQ: RGC) during October 28, 2024 - October 31, 2025 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the Regencell Bioscience Holdings Limited case?
The lead plaintiff deadline for the Regencell Bioscience Holdings Limited lawsuit is June 23, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for Regencell Bioscience Holdings Limited?
The class period for Regencell Bioscience Holdings Limited (NASDAQ: RGC) is October 28, 2024 - October 31, 2025, during which investors may have been affected by alleged misconduct.
- Can I still join the Regencell Bioscience Holdings Limited lawsuit if I sold my shares?
Yes. Investors who purchased Regencell Bioscience Holdings Limited shares during October 28, 2024 - October 31, 2025 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the Regencell Bioscience Holdings Limited lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the Regencell Bioscience Holdings Limited case may receive a portion of the recovery.
- Do I need to pay to participate in the Regencell Bioscience Holdings Limited case?
No, most securities fraud cases involving Regencell Bioscience Holdings Limited operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the Regencell Bioscience Holdings Limited lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the Regencell Bioscience Holdings Limited case on behalf of participants.
- What documents are required for the Regencell Bioscience Holdings Limited lawsuit?
To participate in the Regencell Bioscience Holdings Limited lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for Regencell Bioscience Holdings Limited?
After submission, your details for the Regencell Bioscience Holdings Limited case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the Regencell Bioscience Holdings Limited lawsuit?
No, this page provides information about the Regencell Bioscience Holdings Limited case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the Regencell Bioscience Holdings Limited case?
The lead plaintiff deadline for the Regencell Bioscience Holdings Limited lawsuit is June 23, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
Nektar Therapeutics
NKTR
Lead Plaintiff Deadline: May 5, 2026
Class Period: February 26, 2025 - December 15, 2025
Hercules Capital, Inc.
HTGC
Lead Plaintiff Deadline: May 19, 2026
Class Period: May 1, 2025 - February 27, 2026